The First Affiliated Hospital Of Soochow University

This study tests a treatment that uses a patient's own immune cells, modified to target two proteins (CD19 and BCMA) on myeloma cells, after a stem cell transplant. The goal is to see if this approach is safe and can control high-risk multiple myeloma. About 43 participants will …

This study tests a combination of three drugs (chidamide, azacytidine, and a chemotherapy regimen called HAG) in adults aged 18 to 70 with acute myeloid leukemia that has come back or not responded to standard treatment. The goal is to see if this combination can shrink or elimin…

This study tests a new treatment for adults with a specific type of leukemia (Philadelphia chromosome-positive B-ALL). It combines two types of engineered immune cells: CD19 CAR-T cells and special 'feeding' T cells that mimic leukemia cells to help the CAR-T cells grow and stay …

This study tests a new treatment for non-small cell lung cancer. Doctors take a patient's tumor, create a nanovaccine from it, and use that to grow special T cells that can attack the cancer. These T cells are then given back to the patient. The goal is to see if this approach ca…

This study tests whether N-acetylcysteine (NAC), a common antioxidant, can treat a severe blood clotting condition called TA-TMA that can happen after a stem cell transplant. About 44 adults who develop TA-TMA will receive NAC to see if it improves blood counts and organ function…

This study tests a new PET/CT scan that uses a special radioactive tracer to find a protein called Nectin-4 on solid tumors like breast, bladder, and lung cancers. The goal is to see if this scan can clearly show where these tumors are in the body, which may help doctors choose b…

This study follows 300 people who have persistent low blood cell counts (anemia, low white cells, or low platelets) that cannot yet be diagnosed as a bone marrow disease called myelodysplastic syndromes (MDS). The goal is to track how often these patients progress to MDS or relat…